Penatalaksanaan Gagal Jantung

Oleh :

dr.Eveline Yuniarti

Pilihan penatalaksanaan gagal jantung mencakup modifikasi gaya hidup, terapi medikamentosa di bawah pengawasan dokter spesialis kardiovaskular, rehabilitasi kapasitas olahraga dan aktivitas, hingga pembedahan.[1,2]

Pasien dengan kardiomegali atau gejala khas perlu dikonsultasikan ke dokter spesialis jantung dan pembuluh darah (SpJP), sehingga perlu dirujuk ke fasilitas kesehatan tingkat lanjut. Penanganan gagal jantung bersifat kolaboratif antara dokter spesialis kardiovaskular, dokter umum, perawat, hingga ahli gizi, terutama pada penderita yang sudah mencapai gagal jantung tahap lanjut.[3]

Medikamentosa

Referensi

1. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2022;79:e263–421. https://doi.org/10.1016/j.jacc.2021.12.012.
2. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599–726. https://doi.org/10.1093/eurheartj/ehab368.
3. Kelompok Kerja Gagal Jantung dan Kardiometabolik Perhimpuntan Dokter Spesialis Kardiovaskular Indonesia. Pedoman Tatalaksana Gagal Jantung. vol. 2. Jakarta: 2020.
13. Jia R, Ji Y, Sun D. Progress and prospects of Sacubitril/Valsartan: Based on heart failure with preserved ejection fraction. Biomedicine and Pharmacotherapy 2022;155. https://doi.org/10.1016/j.biopha.2022.113701.
14. Butt JH, Dewan P, Jhund PS, Anand IS, Atar D, Ge J, et al. Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction. J Am Coll Cardiol 2022. https://doi.org/10.1016/j.jacc.2022.06.037.
15. Mohebi R, Liu Y, Michael Felker G, Prescott MF, Ward JH, Piña IL, et al. Heart Failure Duration and Mechanistic Efficacy of Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction. J Card Fail 2022. https://doi.org/10.1016/j.cardfail.2022.08.006.
16. Sattar Y, Song D, Almas T, Zghouzi M, Talib U, Suleiman ARM, et al. Cardiovascular outcomes and trends of Transcatheter vs. Surgical aortic valve replacement among octogenarians with heart failure: A Propensity Matched national cohort analysis. IJC Heart and Vasculature 2022;42. https://doi.org/10.1016/j.ijcha.2022.101119.
17. Xu M, Ji J, Lu Q, Gong J, Luo Z, Zhu L. The effects of thiamine supplementation on patients with heart failure: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med 2022;70. https://doi.org/10.1016/j.ctim.2022.102853.
18. Oppedisano F, Mollace R, Tavernese A, Gliozzi M, Musolino V, Macrì R, et al. PUFA supplementation and heart failure: Effects on fibrosis and cardiac remodeling. Nutrients 2021;13. https://doi.org/10.3390/nu13092965.
19. Xu B, Xu Z, Xu D, Tan X. Effect of n-3 polyunsaturated fatty acids on ischemic heart disease and cardiometabolic risk factors: a two-sample Mendelian randomization study. BMC Cardiovasc Disord 2021;21. https://doi.org/10.1186/s12872-021-02342-6.

(Konten ini khusus untuk dokter. Registrasi untuk baca selengkapnya)

Masuk atau Daftar

Nomor Ponsel Sudah Terdaftar

Masuk dengan Email

Masuk dengan Email

Masuk dengan Facebook

Penatalaksanaan Gagal Jantung

Referensi

Masuk atau Daftar

Artikel Terkait